C85.95
Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) is a type of cancer that originates in lymphocytes, a kind of white blood cell involved in the immune system. The subtype represented by ICD-10 code C85.95 specifically refers to cases where the lymphoma is situated in the lymph nodes located in the inguinal region (groin area) and the lower limbs. This classification underscores the disease's location rather than its specific biological characteristics. It can affect individuals of any age but is more commonly diagnosed in older adults. Understanding this diagnosis involves grasping how NHL develops, its symptoms, methods of diagnosis, and typical treatment options.
Causes & Symptoms
Clinical Causes: Genetic factors, including inherited predispositions. Exposure to certain chemicals, such as pesticides or industrial solvents. Immunosuppression, either due to medical treatments like immunosuppressive therapy or conditions like HIV/AIDS. Previous radiation therapy or chemotherapy. Infections linked to certain viruses, such as Epstein-Barr virus or human T-lymphotropic virus.
Key Symptoms: Swelling or enlargement of lymph nodes in the groin and lower limbs, which may be painless. Unexplained weight loss. Persistent fatigue or weakness. Fever that recurs or persists over time. Night sweats. Itching or skin changes over affected areas. Feeling of fullness in the abdomen or lower limbs due to enlarged lymph nodes. Additional symptoms depending on the extent of disease spread, such as pain or discomfort.
Diagnostic & Treatment
Diagnosis Path: The process of diagnosing non-Hodgkin lymphoma involves several steps to confirm the presence of cancer and determine its specific location and subtype. These include: - Physical examination focusing on lymph node regions, especially the inguinal area and legs. - Imaging tests such as ultrasound, CT scans, or PET scans to identify enlarged lymph nodes and assess spread. - Biopsy procedures, often a biopsy of an enlarged lymph node, to examine tissues microscopically. - Laboratory studies, including blood tests to evaluate overall health and identify abnormal cells. - Bone marrow examination if systemic spread is suspected. While the ICD-10 code specifies the location in the inguinal region and lower limbs, additional tests help refine the diagnosis, staging, and treatment planning.
Treatment Protocols: Management of non-Hodgkin lymphoma varies based on the specific subtype, stage, patient's overall health, and preferences. Common treatment options include: - Chemotherapy: The use of drugs to kill cancer cells, often the mainstay of treatment. - Immunotherapy: Involving agents like monoclonal antibodies that help the immune system target lymphoma cells. - Radiation therapy: Targeted radiation may be used in localized disease. - Targeted therapy: Drugs designed to interfere with specific molecules involved in cancer growth. - Stem cell transplant: For certain cases, high-dose chemotherapy followed by a stem cell transplant may be considered. Supportive care is also essential, including managing symptoms, preventing infections, and providing nutritional support. Close monitoring during and after treatment is critical for assessing response and managing side effects.
Clinical Advice & FAQs
Billing Guidance
Is C85.95 a billable ICD-10 code?
Yes, C85.95 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.95?
Clinical documentation must specify the nature of Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
